Report: 2016 State of the State of Gynecologic Cancers

January 25, 2017 8:04 pm

Today in celebration of its 25th anniversary, the Foundation for Women’s Cancer with the Society of Gynecologic Oncology released a comprehensive report on the most recent advances in the detection and treatment of gynecologic cancers.

The 2016 State of the Read more

More Chemo May Not Equal Better Outcomes in Ovarian Cancer

January 23, 2017 7:56 pm

Increasing the number of cycles of chemotherapy doesn’t appear to significantly influence recurrence rates or survival in patients with early stage ovarian clear cell carcinoma (OCCC), according to researchers.

The retrospective cohort study of 201 patients showed that recurrence and … Read more

Tesaro Opens Expanded Program of PARP inhibitor for U.S. Ovarian Cancer Patients

January 18, 2017 7:31 pm

Tesaro has opened an expanded access program (EAP) in the United States for their investigational poly ADP ribose polymerase (PARP) inhibitor, niraparib.
Now, niraparib is can be available, to treat a patient who meet certain criteria, with a serious disease … Read more

Experts Forecast Cancer Research and Treatment Advances in 2017

January 17, 2017 7:09 pm

As we step into 2017, a big question looming in the minds of all stakeholders in the cancer research arena is: What is the future of cancer research in the new administration? Members of Congress on both sides of the … Read more

New Clinical Trial Combines Two Methods to Defeat Ovarian Cancer

January 12, 2017 3:31 am

Fewer than half of women diagnosed with ovarian cancer live for five years or more. Sarah Adams, MD, a cancer doctor at the UNM Comprehensive Cancer Center, hopes a new therapy that delivers a one-two punch to cancer cells will … Read more

In Ovarian Cancer Advancements, Finding New Biomarkers Is Key

January 5, 2017 9:02 pm

The search for validated, actionable biomarkers may be more important than initiating more phase 3 trials in the field of ovarian cancer, according to Maurie Markman, M.D.

“In the ovarian cancer arena, we have 30 years of history of doing … Read more

Gene Testing Could Help Predict Ovarian Cancer Patients’ Sensitivity

January 2, 2017 7:55 pm

Testing for a gene commonly mutated in ovarian cancers could pick out patients who will respond well to a promising new class of cancer drugs, a major new study reveals.

Scientists found that defects in a gene called ARID1A caused … Read more

Drug Combo Promising in Recurrent Ovarian Cancer

December 27, 2016 8:07 pm

Heavily pre-treated patients with recurrent ovarian cancer have limited options when it comes to regimens that can control disease while maintaining a satisfactory quality of life.

Now, a phase II open-label study has demonstrated that a combination of the camptothecin … Read more

In Battle Against Ovarian Cancer, A New Focus on Fallopian Tubes

December 23, 2016 5:45 pm

Two thin tubes that connect the ovaries to the uterus have assumed an outsize role in the battle against ovarian cancer. Research increasingly points to the likelihood that some of the most aggressive ovarian cancers originate in the fallopian tubes. … Read more

A 23-Year-Old Bodybuilder Is Being Ravaged By Ovarian Cancer — And Instagramming It

December 21, 2016 6:58 pm

Three weeks before her wedding day, Cheyann Shaw uploaded a video to YouTube, a space the fitness fanatic regularly filled with workout clips and health tips. But this time was different: She was now using the social video platform for … Read more

FDA Approves Rucaparib and Genetic Test in Advanced Deleterious BRCA-Mutated Ovarian Cancer

December 20, 2016 6:45 pm

The U.S. Food and Drug Administration (FDA) today granted accelerated approval to rucaparib (Rubraca) to treat women with advanced ovarian cancer who have been treated with two or more chemotherapies and whose tumors have a specific gene mutation (deleterious BRCARead more

In 2017, I Resolve to Move Forward

December 16, 2016 5:59 pm

By: Annette McElhiney

As an amateur artist who paints to heal, I see the various stages I’ve been through in my ovarian cancer journey hanging on the walls surrounding me. Some paintings are full of joy as when I first … Read more

14-Year-Old Cancer Survivor Cast In San Diego Theater’s Ballet

December 14, 2016 7:19 pm

A 14-year-old cancer survivor was cast in her dream role this holiday season only a year after the disease had dashed her hopes to perform as Clara in the Christmas classic The Nutcracker. Caitlyn Feddock, who will perform the role … Read more

Research & Awareness Key To Improving Ovarian Cancer Survivor Rates

December 12, 2016 10:22 pm

Delivering bad news to a patient is one of the toughest parts of being a medical professional. As an ob/gyn, whenever I had a patient that showed signs of ovarian, cervical or uterine cancer, it was my responsibility to inform … Read more

Avastin Gains Expanded FDA Approval for Platinum-Sensitive Ovarian Cancer

December 8, 2016 7:04 pm

Avastin (bevacizumab) gained an expanded FDA approval to treat patients with platinum-sensitive recurrent ovarian cancer as a part of a combination regimen with chemotherapy followed by continued use of the angiogenesis inhibitor, according to the drug developer, Genentech.

The approval … Read more

Seven States Pass Some Form of Marijuana Legalization

December 5, 2016 10:30 pm

Arkansas, California, Florida, Maine, Massachusetts, Nevada, and North Dakota passed some form of marijuana legalization on Election Day 2016, potentially reducing barriers for patients with cancer hoping to use marijuana to relieve symptoms of pain or to increase appetite as … Read more

Treatment Advances in Ovarian Cancer and Other Gynecologic Malignancies

December 1, 2016 7:06 pm

There has been major progress in treating gynecologic malignancies in recent years, especially for ovarian cancer, says Douglas A. Levine, M.D., a member of The Clearity Foundation’s Scientific Advisory Board.

For example, PARP inhibition has gained impressive traction as a … Read more